Loading...
Pityriasis rosea-like Drug Eruption Induced by Imatinib Mesylate (Gleevec™)
Imatinib mesylate (Gleevec™, STI571), a selective inhibitor of BCR-ABL, c-Kit, and platelet-derived factor receptor, has been used to treat chronic myelogenous leukemia (CML) and gastrointestinal stromal tumors. Although its use has been associated with various adverse cutaneous reactions, pityriasi...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Korean Dermatological Association; The Korean Society for Investigative Dermatology
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3276797/ https://ncbi.nlm.nih.gov/pubmed/22346278 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5021/ad.2011.23.S3.S360 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|